Acquisition history Pharmica Consulting was acquired by ProPharma Group in October 2021, signaling a potential exit strategy for vendors and a path to expanded service capabilities or partnership opportunities with the broader ProPharma portfolio.

Small firm leverage With 11-50 employees and revenue under one million dollars, Pharmica presents a target for scalable, high-margin services, training programs, or add-on project management accelerators that complement larger CROs’ workflows.

Biopharma PM niche Specialization in biopharma project management and internal certification suggests a client need for supplementary PM resources, SOP enhancements, and certified project management support during clinical trial execution.

Tech stack fit Current technology use (WordPress, jQuery, Reveal.js, etc.) indicates openness to digital engagement tools; potential upsell of cloud-based PM collaboration platforms, reporting dashboards, and client portals integrated with existing workflows.

Market positioning Compared to large CROs, Pharmica operates with a lean team and focuses on front-line PM expertise; prospects could include co-managed programs, transition services from bigger firms, or strategic partnerships for scalable PM delivery.